Compare PODD & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PODD | PHG |
|---|---|---|
| Founded | 2000 | 1891 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1B | 26.8B |
| IPO Year | 2007 | N/A |
| Metric | PODD | PHG |
|---|---|---|
| Price | $304.01 | $27.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 1 |
| Target Price | ★ $359.00 | N/A |
| AVG Volume (30 Days) | ★ 765.6K | 651.5K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.45 | 0.21 |
| Revenue | $2,521,800,000.00 | ★ $20,861,199,111.00 |
| Revenue This Year | $32.55 | $0.72 |
| Revenue Next Year | $20.39 | $3.11 |
| P/E Ratio | ★ $88.24 | $132.98 |
| Revenue Growth | ★ 27.11 | N/A |
| 52 Week Low | $230.05 | $21.48 |
| 52 Week High | $354.88 | $29.54 |
| Indicator | PODD | PHG |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 42.53 |
| Support Level | $303.20 | $26.30 |
| Resistance Level | $317.34 | $28.32 |
| Average True Range (ATR) | 13.12 | 0.36 |
| MACD | -2.82 | -0.09 |
| Stochastic Oscillator | 3.14 | 32.53 |
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.